View graph of relations

      Research Statement

      The Stratified Medicine Group focuses on the following areas:

      1) Characterisation of a molecular group in solid cancers that represents an innate immune response to DNA damage through the STING pathway.

      2) Development of a biomarker for anti-angiogenic agents

      3) Development of a biomarker for MEKK pathway activation

      4) Identification of a prognostic biomarker for early prostate cancer

      5) Development of new cell lines for pre-clinical modelling of ovarian and prostate cancer.


      Frequent Journals

      • Journal of Clinical Oncology

        ISSNs: 0732-183X, 1527-7755

        Additional searchable ISSN (Electronic): 1527-7755

        American Society of Clinical Oncology

        Scopus rating (2016): SJR 8.883 SNIP 4.894


      • Cancer Research

        ISSNs: 0008-5472

        Additional searchable ISSN (Electronic): 1538-7445

        American Association for Cancer Research Inc.

        Scopus rating (2016): SJR 4.753 SNIP 1.986


      • Molecular Cancer Therapeutics

        ISSNs: 1535-7163

        Additional searchable ISSN (Electronic): 1538-8514

        American Association for Cancer Research Inc.

        Scopus rating (2016): SJR 2.632 SNIP 1.306


      • Lancet

        ISSNs: 0140-6736

        Additional searchable ISSN (Electronic): 1474-547X

        Elsevier Limited

        Scopus rating (2016): SJR 12.467 SNIP 13.698


      • Oncotarget

        ISSNs: 1949-2553

        Impact Journals

        Scopus rating (2016): SJR 1.927 SNIP 1.056


      View all »

      ID: 26639